In the manufacture of pharmaceuticals, encapsulation refers to a range of dosage forms—techniques used to enclose medicines—in a relatively stable shell known as a capsule, allowing them to, for example, be taken orally or be used as suppositories. The two main types of capsules are:
- Hard-shelled capsules, which contain dry, powdered ingredients or miniature pellets made by e.g. processes of extrusion or spheronization. These are made in two halves: a smaller-diameter “body” that is filled and then sealed using a larger-diameter “cap”.
- Soft-shelled capsules, primarily used for oils and for active ingredients that are dissolved or suspended in oil.
Both of these classes of capsules are made from aqueous solutions of gelling agents, such as animal protein (mainly gelatin) or plant polysaccharides or their derivatives (such as carrageenans and modified forms of starch and cellulose). Other ingredients can be added to the gelling agent solution including plasticizers such as glycerin or sorbitol to decrease the capsule's hardness, coloring agents, preservatives, disintegrants, lubricants and surface treatment.
Since their inception, capsules have been viewed by consumers as the most efficient method of taking medication. For this reason, producers of drugs such as OTC analgesics wanting to emphasize the strength of their product developed the “caplet”, a portmanteau of “capsule-shaped tablet”, in order to tie this positive association to more efficiently-produced tablet pills, as well as being an easier-to-swallow shape than the usual disk-shaped tablet Medication
Single-piece gel encapsulation ("soft capsules")
In 1833, Mothes and Dublanc were granted a patent for a method to produce a single-piece gelatin capsule that was sealed with a drop of gelatin solution. They used individual iron molds for their process, filling the capsules individually with a medicine dropper. Later on, methods were developed that used sets of plates with pockets to form the capsules. Although some companies still use this method, the equipment is no longer produced commercially. All modern soft-gel encapsulation uses variations of a process developed by R. P. Scherer in 1933. His innovation used a rotary die to produce the capsules. They were then filled by blow molding. This method was high-yield, consistent, and reduced waste.
Softgels can be an effective delivery system for oral drugs, especially poorly soluble drugs. This is because the fill can contain liquid ingredients that help increase solubility or permeability of the drug across the membranes in the body. Liquid ingredients are difficult to include in any other solid dosage form such as a tablet. Softgels are also highly suited to potent drugs (for example, where the dose is <100 µg), where the highly reproducible filling process helps ensure each softgel has the same drug content, and because the operators are not exposed to any drug dust during the manufacturing process.
In 1949, the Lederle Laboratories division of the American Cyanamid Company developed the "Accogel" process, allowing powders to be accurately filled into soft gelatin capsules.
Two-piece gel encapsulation ("hard capsules")
File:Pharmacological Capsule Diclofenac µCT RIGHT.ogv James Murdoch of London patented the two-piece telescoping gelatin capsule in 1847. The capsules are made in two parts by dipping metal pins in the gelling agent solution. The capsules are supplied as closed units to the pharmaceutical manufacturer. Before use, the two halves are separated, the capsule is filled with powder or more normally pellets made by the process of extrusion and spheronization (either by placing a compressed slug of powder into one half of the capsule, or by filling one half of the capsule with loose powder) and the other half of the capsule is pressed on. With the compressed slug method, weight varies less between capsules. However, the machinery required to manufacture them is more complex.
Gelatin capsules, informally called gel caps or gelcaps, are composed of gelatin manufactured from the collagen of animal skin or bone.
Vegetable capsules, introduced in 1989, are made up of cellulose, an important structural component in plants. To be more specific, the main ingredient of vegetarian capsules is hydroxypropyl methyl cellulose (HPMC). In the current market, gelatin capsules are more broadly used than vegetarian capsules because the cost of production is lower.
The process of encapsulation of hard gelatin capsules can be done on manual, semi-automatic, and automatic capsule filling machines. Hard gelatin capsules are manufactured by the dipping method which is dipping, rotation, drying, stripping, trimming, and joining. Softgels are filled at the same time as they are produced and sealed on the rotary die of a fully automatic machine. Capsule fill weight is a critical attribute in encapsulation and various real-time fill weight monitoring techniques such as near-infrared spectroscopy (NIR) and vibrational spectroscopy are used, as well as in-line weight checks, to ensure product quality.
Volume is measured to the fill line, which is customarily to the top of the smaller-diameter body half.(citation?) After capping, some ullage volume (air space) remains in the finished capsule.
Standard sizes of two-piece capsules
|Size||Volume (mL)[A]||Locked length (mm)[A]||External diameter (mm)[A]|
Drug-embedded empty capsule shells
A new class of capsule has been developed whereby drugs can be embedded in the capsule shell matrix. This allows different drugs to be delivered using the same capsule. The drug might be in a solubilized form, suspended form or chemically bound form in the capsule shell matrix. The drug can be in the cap of the capsule, body of the capsule or in both body and cap of the capsule. One can embed more than one drug in the capsule shell matrix. The drug can be in the dissolved and suspended form in the capsule shell matrix. Thus, one can create various types of variations in these "drug-embedded capsules". The rate of release of drug can vary based on the way drug is embedded in the capsule shell matrix and drug properties. 
- Capsule endoscopy
- Pharmacy Automation - The Tablet Counter
- Pharmaceutical formulation
- Pill splitting
- Safire, William (1986-03-09). "On Language; The Caplet Solution". The New York Times. https://www.nytimes.com/1986/03/09/magazine/on-language-the-caplet-solution.html. Retrieved 2017-12-06.
- "History of dosage forms and basic preparations". Encyclopedia of Pharmaceutical Technology. 7. Informa Health Care. 1998. pp. 304–306. ISBN 0-8247-2806-8. https://archive.org/details/geneticengineeri0007unse/page/304.
- Bill Bennett; Graham Cole (2003). Pharmaceutical Production, an Engineering Guide. IChemE. pp. 126–129. ISBN 0-85295-440-9.
- "Why can't all drugs be vegetarian?". https://www.bmj.com/bmj/section-pdf/752705?path=/bmj/348/7944/Analysis.full.pdf.
- "Pharmaceutical Encapsulation". http://www.pharmacmc.com/encapsulation/.
- Joshi, H.N., Tara Innovations LLC, 2014. Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells. U.S. Patent 8,728,521.
- Joshi, H.N., 2018. Physically dispersed, molecularly dissolved and/or chemically bound drugs in an empty, hard capsule shell composition. U.S. Patent 9,884,024.
- L. Lachman; H.A. Lieberman; J.L. Kanig (1986). The Theory and Practice of Industrial Pharmacy (Third ed.). Lea & Febiger, Philadelphia. ISBN 0-8121-0977-5.
- Hemant N. Joshi, US Patent #8,728,521 (May 20, 2014).
- Hemant N. Joshi, US Patent # 9,884,024 (February 6, 2018).
- Hemant N. Joshi, US Patent # 10,357,461 (July 23, 2019).
- Harshada Sant, MS, "Joshi Capsules" US Patent Numbers # 8,728,521 and # 9,884,024, American Pharmaceutical Review, Page 60, April 2018.
Original source: https://en.wikipedia.org/wiki/ Capsule (pharmacy). Read more